Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-Administration on the Pharmacokinetics of Neramexane.

Trial Profile

Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-Administration on the Pharmacokinetics of Neramexane.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Jan 2010

At a glance

  • Drugs Clopidogrel; Neramexane
  • Indications Alzheimer's disease; Coronary disorders; Thrombosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 Dec 2009 Actual end date (1 Dec 2009) added as reported by ClinicalTrials.gov.
    • 11 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top